Transtheoretical model intervention for adherence to lipid-lowering drugs

Disease Management

Volumn 9, Issue 2, 2006, Pages 102-114

  Johnson, Sara S ^a,c   Driskell, Mary Margaret ^a   Johnson, Janet L ^a   Dyment, Sharon J ^a   Prochaska, James O ^a   Prochaska, Janice M ^a   Bourne, Leslie ^b  

^a Pro Change Behavior Systems Incorporated   (United States)

^b Fallon Clinic   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; EXERCISE; EXPERT SYSTEM; FAT INTAKE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; THEORETICAL MODEL; TRANSTHEORETICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; DIET, FAT-RESTRICTED; EXERCISE; EXPERT SYSTEMS; FEEDBACK; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT SELECTION; UNITED STATES;

EID: 33646519475     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2006.9.102     Document Type: Article

References (42)

1. Gidron Y. Adherence in hypertension and coronary heart disease. In: Myers LB, Midence K, eds. Adherence to treatment in medical conditions. Australia: Harvard Academic Publisher, 1998:473-496.
2. American Heart Association. Cholesterol statistics Available at: www.americanheart.org/presenter. jhtml?identifier=536. Accessed February 14, 2006.
3. Gotto AM. Risk factor modification: rationale for management of dyslipidemia. Am J Med 1998;104:6S-8S.
4. National Heart, Lung, and Blood Institute. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood; Pressure. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, 1997.
5. Luepker RV. Current status of cholesterol treatment in the community: the Minnesota Heart Survey. Am J Med 1997;102:37-42.
6. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997;102:43-49.
7. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19:239-263.
8. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2004 Oct 18;4:CD004371.
9. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002;2:CD000011.
10. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-2879.
11. [Erratum in JAMA 2003;289:3242.]
12. Allen JK, Blumenthal MD, Margolis S, Young DR, Miller ER, Kelly K. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Am Heart J 2002;144:678-686.
13. O'Connor PJ, Rush WA, Trence DL. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization. J Family Practice 1997;44:462-467.
14. Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999;1:477-481.
15. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000;22:1-14.
16. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-395.
17. Prochaska JO, DiClemente CC, Norcross J. In search of how people change. Applications to addictive behaviors. Am Psychol 1992;47:1102-1114.
18. Velicer WF, DiClemente CC, Prochaska JO, Brandenburg N. Decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol 1985;48:1279-1289.
19. Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994;13:39-46.
20. Hall K, Rossi JS. Examining the transtheoretical model using meta-analytic procedures and integrative analysis and longitudinal data. In: Keller S, Velicer WF, eds. Research on the transtheoretical model: where are we now, where are we going? Lengerich, Germany: Pabst Science Publishers, 2004:56-58.
21. Hall K. A meta-analytic examination of decisional balance across stage transitions: a cross-sectional analysis and longitudinal cross-validation. [Doctoral dissertation]. Providence: University of Rhode Island, 2004.
22. Prochaska JO, Velicer WF, DiClemente CC, Rossi JS. Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol 1988;56:520-528.
23. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Newbury Park, CA: Sage Publications, 1992.
24. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.
25. Negotia UN. Expert systems and fuzzy systems. Menlo Park, CA: Benjamin/Cummings, 1985.
26. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993;12:399-405.
27. Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addict Behav 2001;26:583-602.
28. Prochaska JO, Velicer WF, Fava JL, et al. Counselor and stimulus control enhancements of a stage-matched expert system intervention for smokers in a managed care setting. Prev Med 2001;32:23-32.
29. Lawrence T, Aveyard P, Evans O, Cheng KK. A cluster randomised controlled trial of smoking cessation in pregnant women comparing interventions based on the transtheoretical (stages of change) model to standard care. Tob Control 2003;12:168-177.
30. Prochaska JO, Velicer WF, Fava J, Rossi J. Outcome analysis for a multiple risk factor intervention: adolescent sample (in preparation).
31. Evers KE, Prochaska JO, Mauriello LM, Johnson JL, Padula JA, Prochaska JM. A randomized clinical trial of a population and transtheoretical-based stress management intervention. Health Psychol (in press).
32. Evers KE, Prochaska JO, Van Marter D, Johnson JL, Prochaska JM. Transtheoretical-Based bullying prevention effectiveness trials in middle schools and high schools (submitted).
33. Levesque DA, Driskell MM, Prochaska JM. Acceptability of a stage-matched expert system intervention for domestic violence offenders. Violence Victims (in press).
34. Prochaska JO, Velicer WF, Rossi JS, et al Impact of simultaneous stage-matched expert systems for multiple behaviors in a population of parents. Health Psychol 2004;23:503-516.
35. Prochaska JO, Velicer WF, Redding CA, et al. Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer and receive regular mammograms. Prev Med 2005;41:406-416.
36. Jones H, Edwards L, Vallis TM, et al. Changes in diabetes self-care behaviors make a difference in glycemic control: The Diabetes Stages of Change (DiSC) study. Diabetes Care 2003;26:732-737.
37. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
38. Laird NM, Ware H. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
39. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum, 1988.
40. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, 2000.
41. Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull 1992;111:23-41.
42. Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translations of health promotion research to practice? Rethinking the efficacy to effectiveness transition. Am J Public Health 2003;93:1261-1267.